GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas(DIPG) & Spinal Diffuse Midline Glioma(DMG)
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to test whether GD2-CAR T cells can be successfully made
from immune cells collected from children and young adults with H3K27M-mutant diffuse
intrinsic pontine glioma (DIPG) or spinal H3K27M-mutant diffuse midline glioma (DMG).
H3K27Mmutant testing will occur as part of standard of care prior to enrollment.